Day One Biopharmaceuticals (NASDAQ:DAWN) Given Buy Rating at HC Wainwright
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a report issued on Thursday,Benzinga reports. They currently have a $36.00 price target on the stock. HC Wainwright’s target price indicates a potential upside of 398.61% from the stock’s previous close. DAWN has been […]
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a report issued on Thursday,Benzinga reports. They currently have a $36.00 price target on the stock. HC Wainwright’s target price indicates a potential upside of 398.61% from the stock’s previous close. DAWN has been […]
